Skip to contentH
Healthstream Inc
H
HSTMHealthstream Inc Q2 2024 · 10-Q
Revenue$71.56M$71.56M+3.4% vs Q2 2023 Net Income$4.17M$4.17M+0.8% vs Q2 2023 EPS Diluted$0.14$0.14+7.7% vs Q2 2023 Operating Income$4,411,000+10.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Healthstream Inc · CIK 1095565 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$6,279,000+41.3% Margins · derivedOperating margin6.2%+0.4 pt vs Q2 2023
Net margin5.8%−0.1 pt vs Q2 2023
ended Jun 30, 2024 · filed Jul 25, 2024 · 25 d after period end